S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SLRX Salarius Pharmaceuticals Inc

1.89

0.04 (2.16%)

Last Updated: 08:41:58

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Salarius Pharmaceuticals (NASDAQ:SLRX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Salarius Pharmaceuticals Charts.

Salarius Pharmaceuticals (NASDAQ:SLRX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Salarius Pharmaceuticals Charts.

Salarius Pharmaceuticals Inc News

Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers
Monday 3 February 2025 (1 week ago) • GlobeNewswire Inc.

Form S-1 - General form for registration of securities under the Securities Act of 1933
Tuesday 21 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 17 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 13 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement
Monday 13 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Sunday 29 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Monday 16 December 2024 (2 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Friday 1 November 2024 (3 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Friday 1 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 27 September 2024 (4 months ago) • Edgar (US Regulatory)

More Salarius Pharmaceuticals Inc News Articles

Kraig Biocraft Laborator... (QB)

TPT Global Tech (CE)

RespireRx Pharmaceuticals (CE)

Intergrated Cannabis Sol... (PK)

North Bay Resources (PK)

NioCorp Developments

TheGlobe com (PK)

Rennova Health (CE)

Lightwave Logic

Bioelectronics (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions